Information on Third mRNA COVID-19 Vaccine Dose Added to NCCN Guidance for People With Cancer NCCN announced significant updates to the NCCN: Cancer and COVID-19 Vaccination guidance. This is the fourth version of NCCN’s COVID-19 vaccination
Search Results
Emily A. Harlan and Andrew G. Shuman
COVID-19 pandemic. 1 Drug shortages are a systematic problem: a manifestation of perverse incentives for pharmaceutical companies and other stakeholders, and of the fundamentally broken healthcare system in which we work. Drug shortages are often a
NCCN 2021 Virtual Annual Conference Addresses Cancer Care in a Year of Crisis and Innovation New recommendations to advance racial equity, ways to mitigate the impacts of the COVID-19 pandemic on cancer care, and ongoing strategies for
NCCN Updates Recommendations for COVID-19 Vaccination With Information on Bivalent Vaccines, Children With Cancer, and Other Developments NCCN has released updated recommendations from the NCCN Advisory Committee on COVID-19 Vaccination and
NCCN Cancer Experts Answer Questions About COVID-19 Vaccines NCCN has published new guidance on COVID-19 vaccines for people with cancer, intended to clear up confusion for patients and caregivers. The new 4-page patient guide is based on the
William Alex Carson, Delecia Robinson, Lisa Scott, Tracie Lewis, Becky Eaddy, Annie Thibault, and Frank Berger
The COVID-19 shutdown halted elective procedures and limited in-person meetings, causing the Colorectal Cancer Prevention Network (CCPN) screening program to cease for 3 months. During this time, the CCPN focused on developing virtual patient
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Alberto Delgado-Iribarren Garcia-Campero, Elvira Baos Muñoz, Sara Gil Useros, and Pedro Perez Segura
vaccine dose. Antibody titers were measured using the SARS-CoV-2 IgG II Quant assay. There was no possibility of collecting the samples within a prespecified window due to the strict COVID-19 restrictions which prevented the patients from attending to
Amye Tevaarwerk, Travis Osterman, Waddah Arafat, Jeffrey Smerage, Fernanda C.G. Polubriaginof, Tricia Heinrichs, Jessica Sugalski, and Daniel Martin
Introduction: The use of telemedicine in the oncology (Onc) setting expanded after March 2020 due to the COVID-19 pandemic. Patients and providers report satisfaction with telemedicine within the context of acute pandemic needs (Darcourt et al, JOP
Updated Guidance for COVID-19 Vaccination From NCCN Recommends Fifth mRNA Shot (Second Booster Dose) for Immunocompromised People On April 27th, 2022, NCCN released the latest recommendations from the NCCN Advisory Committee on COVID-19
Protecting People With Cancer From COVID-19: New Recommendations From Cancer Guidelines Organization On January 4, 2022, NCCN published significant updates to the expert consensus recommendations on vaccination and pre-exposure prophylaxis of
